NCT07137091Completed
Motion for Recovery: The Impact of Gyrokinesis on Childhood Cancer-Related Fatigue.
Source: ClinicalTrials.gov · Last updated 3 Mar 2026
Brief summary (registry, in English)
CRF influences engagement in everyday activities, mood, sleep, social relations, school attendance, academic achievement, and quality of life . It was significantly associated with low health-related quality of life in pediatric cancer patients including leukemia . Since attention to managing cRF has been drawn, only a few non-pharmacological strategies were tested for their effectiveness in reducing cRF among children. Physical activity (Pa) has been proven to be the most effective strategy . Yet adherence to Pa remains problematic.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 80 (actual)
- First submitted
- 16 Aug 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 1 Feb 2026
- Lead sponsor
- MTI University
- Diseases
- Childhood cancers
- NCT number
- NCT07137091
What you commit to
- Study type: Interventional
- Participants enrolled: 80
- From 1 Oct 2025 to the primary completion date, 1 Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of recent poorly controlled seizures.
- Motor tics or Tourette syndrome (including family history of tic disorder).
- Known diagnosis of Attention Deficit/Hyperactivity Disorder or Autism Spectrum Disorder.
- Known diagnosis of Full Scale Intelligence Quotient (FSIQ) of \<50.
- Pregnancy. Participants known to be pregnant or breastfeeding at screening/registration will not enrolled
Who the study is looking for
- Diagnosed and treated for a brain tumor during childhood or adolescence (0-≤18 years).
- Treated for a PBT during the previous 10 years, starting from date of diagnosis.
- Aged ≥6 years 0 months at the start of the trial.
- Off therapy/active treatment for pediatric brain tumor (PBT) for 12 months at the start of the trial.
- No known signs of clinical or radiological tumor progression at last follow-up.
- Danish is the sole or primary language (enabling provision of validated assessment tools).
- Patient and family have provided consent for inclusion in the trial.
Age in the registry: 12 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| faculty of physical therapy, Cairo university Coordinator of this site? Confirm its status | Cairo | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.